Céléna Dubuc

408 total citations
13 papers, 329 citations indexed

About

Céléna Dubuc is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Céléna Dubuc has authored 13 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Céléna Dubuc's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers), Peptidase Inhibition and Analysis (4 papers) and Estrogen and related hormone effects (2 papers). Céléna Dubuc is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers), Peptidase Inhibition and Analysis (4 papers) and Estrogen and related hormone effects (2 papers). Céléna Dubuc collaborates with scholars based in Canada, United States and Italy. Céléna Dubuc's co-authors include François Bénard, Martin Savard, Fernand Gobeil, Jérôme Côté, Johan E. van Lier, Veronica Bovenzi, Witold Neugebauer, Jacques Rousseau, Naseem Ahmed and Simon Authier and has published in prestigious journals such as PLoS ONE, Journal of Cellular Physiology and Oncotarget.

In The Last Decade

Céléna Dubuc

12 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Céléna Dubuc Canada 12 151 94 57 53 41 13 329
Michael R. Huff United States 5 234 1.5× 92 1.0× 42 0.7× 60 1.1× 30 0.7× 10 440
Linhong Sun United States 12 291 1.9× 109 1.2× 38 0.7× 122 2.3× 36 0.9× 18 606
Flora Vitale Italy 12 187 1.2× 88 0.9× 49 0.9× 117 2.2× 20 0.5× 16 401
Lanchun Ni China 13 228 1.5× 130 1.4× 39 0.7× 45 0.8× 16 0.4× 20 464
Mona Al-Gizawiy United States 12 186 1.2× 93 1.0× 14 0.2× 58 1.1× 44 1.1× 18 385
Andréia Vasconcelos-dos-Santos Brazil 11 299 2.0× 86 0.9× 44 0.8× 45 0.8× 20 0.5× 14 470
Verena Leidgens Germany 7 219 1.5× 137 1.5× 21 0.4× 115 2.2× 26 0.6× 8 452
Xifeng Fei China 14 301 2.0× 103 1.1× 23 0.4× 120 2.3× 15 0.4× 38 606
Tércia Alves Brazil 9 246 1.6× 114 1.2× 32 0.6× 67 1.3× 20 0.5× 10 470
Christof Renner Germany 11 106 0.7× 164 1.7× 18 0.3× 63 1.2× 82 2.0× 17 533

Countries citing papers authored by Céléna Dubuc

Since Specialization
Citations

This map shows the geographic impact of Céléna Dubuc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céléna Dubuc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céléna Dubuc more than expected).

Fields of papers citing papers by Céléna Dubuc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Céléna Dubuc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céléna Dubuc. The network helps show where Céléna Dubuc may publish in the future.

Co-authorship network of co-authors of Céléna Dubuc

This figure shows the co-authorship network connecting the top 25 collaborators of Céléna Dubuc. A scholar is included among the top collaborators of Céléna Dubuc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Céléna Dubuc. Céléna Dubuc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Savard, Martin, Frédéric Couture, Céléna Dubuc, et al.. (2025). Theranostic Potential of a New 64Cu-Labeled NOTA-R954 Peptide Conjugate for Kinin B1R Expressing Prostate Cancer. Pharmaceutics. 17(9). 1215–1215.
2.
Dubuc, Céléna, Martin Savard, Veronica Bovenzi, et al.. (2018). Antitumor activity of cell‐penetrant kinin B1 receptor antagonists in human triple‐negative breast cancer cells. Journal of Cellular Physiology. 234(3). 2851–2865. 16 indexed citations
3.
Dubuc, Céléna, Martin Savard, Veronica Bovenzi, et al.. (2018). Targeting intracellular B2 receptors using novel cell-penetrating antagonists to arrest growth and induce apoptosis in human triple-negative breast cancer. Oncotarget. 9(11). 9885–9906. 18 indexed citations
4.
Savard, Martin, Julie Labonté, Céléna Dubuc, et al.. (2013). Further pharmacological evaluation of a novel synthetic peptide bradykinin B2 receptor agonist. Biological Chemistry. 394(3). 353–360. 16 indexed citations
5.
Côté, Jérôme, Veronica Bovenzi, Martin Savard, et al.. (2012). Induction of Selective Blood-Tumor Barrier Permeability and Macromolecular Transport by a Biostable Kinin B1 Receptor Agonist in a Glioma Rat Model. PLoS ONE. 7(5). e37485–e37485. 42 indexed citations
6.
Pampillo, Macarena, Martin Savard, Céléna Dubuc, et al.. (2010). The Human Gonadotropin Releasing Hormone Type I Receptor Is a Functional Intracellular GPCR Expressed on the Nuclear Membrane. PLoS ONE. 5(7). e11489–e11489. 45 indexed citations
7.
Côté, Jérôme, Martin Savard, Veronica Bovenzi, et al.. (2010). Selective tumor blood–brain barrier opening with the kinin B2 receptor agonist [Phe8ψ(CH2NH)Arg9]-BK in a F98 glioma rat model: An MRI study. Neuropeptides. 44(2). 177–185. 26 indexed citations
8.
Guérin, Brigitte, Véronique Dumulon‐Perreault, Samia Aït‐Mohand, et al.. (2009). [Lys(DOTA)4]BVD15, a novel and potent neuropeptide Y analog designed for Y1 receptor-targeted breast tumor imaging. Bioorganic & Medicinal Chemistry Letters. 20(3). 950–953. 36 indexed citations
9.
Authier, Simon, Sébastien Tremblay, Céléna Dubuc, et al.. (2008). [11C] Acetoacetate Utilization by Breast and Prostate Tumors: a PET and Biodistribution Study in Mice. Molecular Imaging and Biology. 10(4). 217–223. 21 indexed citations
10.
Côté, Jérôme, Martin Savard, Veronica Bovenzi, et al.. (2008). Novel kinin B1 receptor agonists with improved pharmacological profiles. Peptides. 30(4). 788–795. 26 indexed citations
11.
Bénard, François, Naseem Ahmed, Jean‐Mathieu Beauregard, et al.. (2008). [18F]Fluorinated estradiol derivatives for oestrogen receptor imaging: impact of substituents, formulation and specific activity on the biodistribution in breast tumour-bearing mice. European Journal of Nuclear Medicine and Molecular Imaging. 35(8). 1473–1479. 20 indexed citations
12.
Dubuc, Céléna, Réjean Langlois, François Bénard, et al.. (2008). Targeting gastrin-releasing peptide receptors of prostate cancer cells for photodynamic therapy with a phthalocyanine–bombesin conjugate. Bioorganic & Medicinal Chemistry Letters. 18(7). 2424–2427. 34 indexed citations
13.
Ahmed, Naseem, Céléna Dubuc, Jacques Rousseau, François Bénard, & Johan E. van Lier. (2007). Synthesis, characterization, and estrogen receptor binding affinity of flavone-, indole-, and furan-estradiol conjugates. Bioorganic & Medicinal Chemistry Letters. 17(11). 3212–3216. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael R. Huff Breakdown of academic impact, for papers by Linhong Sun Breakdown of academic impact, for papers by Flora Vitale Breakdown of academic impact, for papers by Lanchun Ni Breakdown of academic impact, for papers by Mona Al-Gizawiy Breakdown of academic impact, for papers by Andréia Vasconcelos-dos-Santos Breakdown of academic impact, for papers by Verena Leidgens Breakdown of academic impact, for papers by Xifeng Fei Breakdown of academic impact, for papers by Tércia Alves Breakdown of academic impact, for papers by Christof Renner
Rankless by CCL
2026